Zacks Research Issues Positive Forecast for Palomar Earnings

Palomar Holdings, Inc. (NASDAQ:PLMR) – Research analysts at Zacks Research lifted their Q2 2026 EPS estimates for shares of Palomar in a report issued on Monday, March 16th. Zacks Research analyst Team now forecasts that the company will earn $2.00 per share for the quarter, up from their prior estimate of $1.95. The consensus estimate for Palomar’s current full-year earnings is $5.99 per share. Zacks Research also issued estimates for Palomar’s Q3 2026 earnings at $2.57 EPS, Q4 2026 earnings at $2.34 EPS, FY2026 earnings at $8.98 EPS and Q3 2027 earnings at $2.76 EPS.

Several other equities analysts have also weighed in on the stock. Keefe, Bruyette & Woods lifted their target price on shares of Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a report on Tuesday, January 6th. JPMorgan Chase & Co. increased their price target on Palomar from $155.00 to $160.00 and gave the company an “overweight” rating in a report on Monday, February 23rd. Weiss Ratings raised Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, January 14th. Wall Street Zen cut Palomar from a “buy” rating to a “hold” rating in a research note on Sunday, March 1st. Finally, Evercore started coverage on Palomar in a research report on Monday, February 9th. They issued an “outperform” rating and a $150.00 target price for the company. Seven equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $163.00.

Palomar Stock Down 1.5%

Palomar stock opened at $117.25 on Wednesday. The firm has a fifty day moving average of $125.42 and a 200-day moving average of $123.17. Palomar has a 52-week low of $107.75 and a 52-week high of $175.85. The firm has a market capitalization of $3.13 billion, a P/E ratio of 16.33 and a beta of 0.46.

Palomar (NASDAQ:PLMR) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.06 by $0.18. Palomar had a net margin of 22.50% and a return on equity of 22.77%. The firm had revenue of $253.36 million for the quarter, compared to analyst estimates of $204.58 million. During the same quarter last year, the firm posted $1.52 earnings per share. Palomar’s revenue for the quarter was up 62.7% compared to the same quarter last year.

Insider Buying and Selling at Palomar

In related news, CEO Mac Armstrong sold 5,000 shares of Palomar stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $122.60, for a total transaction of $613,000.00. Following the sale, the chief executive officer owned 343,388 shares of the company’s stock, valued at $42,099,368.80. The trade was a 1.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Angela L. Grant sold 260 shares of the business’s stock in a transaction on Saturday, January 31st. The stock was sold at an average price of $121.75, for a total transaction of $31,655.00. Following the completion of the transaction, the insider owned 7,033 shares in the company, valued at $856,267.75. This represents a 3.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 58,999 shares of company stock worth $7,253,229. 3.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Summit Global Investments grew its stake in Palomar by 1.7% during the 4th quarter. Summit Global Investments now owns 4,646 shares of the company’s stock valued at $626,000 after purchasing an additional 79 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Palomar by 3.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,546 shares of the company’s stock valued at $333,000 after purchasing an additional 82 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Palomar by 2.0% during the 4th quarter. Quadrant Capital Group LLC now owns 4,464 shares of the company’s stock valued at $602,000 after buying an additional 88 shares during the last quarter. Clearstead Advisors LLC boosted its stake in shares of Palomar by 31.0% during the 3rd quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock valued at $46,000 after buying an additional 94 shares during the last quarter. Finally, California State Teachers Retirement System grew its position in shares of Palomar by 0.4% during the second quarter. California State Teachers Retirement System now owns 24,207 shares of the company’s stock worth $3,734,000 after buying an additional 97 shares in the last quarter. Institutional investors and hedge funds own 90.25% of the company’s stock.

More Palomar News

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Zacks published a bullish piece highlighting three reasons growth investors shouldn’t overlook Palomar, emphasizing the company’s solid growth attributes and potential to outpace the market. Read More.
• Positive Sentiment: Zacks also raised several near-term EPS estimates (notably Q1 & Q2 2027, and upgrades to Q2 2026 and Q4 2026), and lifted FY2027 guidance—supporting the view of continued earnings momentum in the short term.
• Neutral Sentiment: A Q4 earnings roundup places Palomar within the broader property & casualty insurance peer group, providing context on underwriting, reserve and investment trends but offering no new company-specific catalyst. Read More.
• Negative Sentiment: Offsetting the positives, Zacks trimmed some mid- and longer-term estimates (cuts to Q3 2026 and Q3 2027 EPS, a small reduction to FY2026, and a noticeable downgrade to FY2028), signaling more conservative assumptions about future growth and introducing downside risk to sentiment.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.